Open access
453
Views
0
CrossRef citations to date
0
Altmetric
Special Report
How will the identification and therapeutic intervention of genetic targets in oncology evolve for future therapy?
Paolo Baldoa Hospital Pharmacy Unit, Centro di Riferimento Oncologico di Aviano, CRO Aviano, National Cancer Institute, IRCCS, Aviano, ItalyCorrespondence[email protected]
https://orcid.org/0000-0002-5106-7120View further author information
, https://orcid.org/0000-0002-5106-7120View further author information
Valli De Reb Immunopathology and Cancer Biomarkers Unit, Centro di Riferimento Oncologico di Aviano, CRO Aviano, National Cancer Institute, IRCCS, Aviano, ItalyView further author information
& Mattia Garuttic Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano, CRO Aviano, National Cancer Institute, IRCCS, Aviano, ItalyView further author information
Pages 1189-1194
|
Received 23 Jul 2023, Accepted 12 Dec 2023, Published online: 20 Dec 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.